Nicolae D. Hancu
Cluj-napoca, CJ, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 11, 2021
Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European Perspective.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 29, 2021
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial.
Journal: The lancet. Diabetes & endocrinology
Published: November 18, 2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Journal: Lancet (London, England)
Published: April 14, 2019
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: April 14, 2019
Prevalence of dyslipidemia and its association with cardiometabolic factors and kidney function in the adult Romanian population: The PREDATORR study.
Journal: Diabetes & metabolic syndrome
Published: October 18, 2018
Hypertensive Waist and Lipid Accumulation Product as Predictors of Metabolic Syndrome.
Journal: Metabolic syndrome and related disorders
Published: October 10, 2018
Associations of smoking with cardiometabolic profile and renal function in a Romanian population-based sample from the PREDATORR cross-sectional study.
Journal: The European journal of general practice
Published: June 10, 2017
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.
Journal: European heart journal supplements : journal of the European Society of Cardiology
Published: May 24, 2017
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.
Journal: Diabetes, obesity & metabolism
Published: April 19, 2017
UPDATING THE CONCEPT OF METABOLICALLY HEALTHY OBESITY.
Journal: Acta endocrinologica (Bucharest, Romania : 2005)
Published: April 01, 2016
Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis.
Journal: Romanian journal of internal medicine = Revue roumaine de medecine interne
Published: March 11, 2016
Last Updated: 09/26/2026